Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
26 |
Employees |
- |
Revenues (TTM) (Millions $) |
57 |
Net Income (TTM) (Millions $) |
-17 |
Cash Flow (TTM) (Millions $) |
-61 |
Capital Exp. (TTM) (Millions $) |
5 |
Oxford Immunotec Global Plc
Oxford Immunotec Global Plc is a biotechnology company that specializes in the development, manufacture, and marketing of immunodiagnostic tests for the detection and monitoring of immune-regulated conditions. The company's main product is the T-SPOT.TB test, which is used to diagnose and monitor tuberculosis infection. They also have other tests for a range of diseases including Lyme disease and immune disorders. Oxford Immunotec is headquartered in Abingdon, United Kingdom, and operates globally. The company's goal is to provide accurate and reliable diagnostic solutions to improve patient care and support public health efforts.
Company Address: 94C Innovation Drive Milton Park 0
Company Phone Number: 1235 442780 Stock Exchange / Ticker: NASDAQ OXFD
|